Revlimid and Levophed drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Revlimid (lenalidomide) and Levophed (norepinephrine bitartrate). Common drug interactions include barrett's oesophagus among females and pancytopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Revlimid and Levophed. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.
What is Levophed?
Levophed has active ingredients of norepinephrine bitartrate. eHealthMe is studying from 2,047 Levophed users. Check the latest studies of Levophed.
46 people who take Revlimid and Levophed together, and have interactions are studied.

What are the common drug interactions of Revlimid and Levophed, by gender? *:
female:
- Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
- Cardiogenic shock (inadequate circulation of blood)
- Hypertension (high blood pressure)
- Intervertebral disc degeneration (spinal disc degeneration)
- Memory impairment
- Neuropathy peripheral (surface nerve damage)
- Scoliosis (a medical condition in which a person's spine is curved from side to side)
- Sepsis syndrome (a clinical condition of blood infection)
- Spinal column stenosis (narrowing of spinal column)
- Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
male:
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pneumonia
- Respiratory distress (difficulty in breathing)
- Septic shock (shock due to blood infection)
- Blood potassium decreased
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Disease progression
- Hypotension (abnormally low blood pressure)
- Nausea (feeling of having an urge to vomit)
- Pneumonia viral
What are the common drug interactions of Revlimid and Levophed, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pneumonia viral
- Multi-organ failure (multisystem organ failure)
- Renal failure acute (rapid kidney dysfunction)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood alkaline phosphatase increased
- Cardiac failure congestive
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
50-59:
- Pneumonia
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Multi-organ failure (multisystem organ failure)
- Acute hepatic failure
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Atelectasis (partial or complete collapse of the lung)
- Back pain
- Bacteraemia (presence of bacteria in the blood)
- Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
- Septic shock (shock due to blood infection)
60+:
- Pneumonia
- Renal failure acute (rapid kidney dysfunction)
- Asthenia (weakness)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Septic shock (shock due to blood infection)
- Urinary tract infection
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Vomiting
- Blood pressure systolic decreased
- Cardiac arrest
What are the existing conditions these people have? *
- Pain: 9 people, 19.57%
- Nausea (feeling of having an urge to vomit): 7 people, 15.22%
- Amyloidosis (a tumour within which amyloid is produced): 7 people, 15.22%
- Hypotension (abnormally low blood pressure): 6 people, 13.04%
- Stress And Anxiety: 5 people, 10.87%
- Adverse Event: 5 people, 10.87%
- Insomnia (sleeplessness): 4 people, 8.70%
- Dyspnea (difficult or laboured breathing): 4 people, 8.70%
- Bacterial Infection: 4 people, 8.70%
- Pneumonia: 3 people, 6.52%
* Approximation only. Some reports may have incomplete information.
Do you take Revlimid and Levophed?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Revlimid and Levophed:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Revlimid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Levophed:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Revlimid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Levophed and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lenalidomide and norepinephrine bitartrate (the active ingredients of Revlimid and Levophed, respectively), and Revlimid and Levophed (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin B6 vs. Citalopram Hydrobromide, side effect and effectiveness comparison - 8 seconds ago
- Zoloft vs. Loraz, side effect and effectiveness comparison - 11 seconds ago
- Could Clotrimazole cause Haemorrhoids? - 13 seconds ago
- Drug interactions of Ergocalciferol and Marine Triglyceride - 14 seconds ago
- Fibromyalgia and Skin Discoloration - 15 seconds ago
- Drug interactions of Clarinex and Betaseron - 29 seconds ago
- Drug interactions of Gocovri and Spironolactone - 35 seconds ago
- Could Trintellix cause Chronic Kidney Disease? - 37 seconds ago
- Could Psyllium Husk cause Asthma? - 37 seconds ago
- Could Baby Aspirin cause Ear Discomfort? - 56 seconds ago